{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:40:55Z","timestamp":1649072455773},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"FI1","license":[{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/europace\/eux358","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T23:01:29Z","timestamp":1516316489000},"page":"f137-f137","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility of drugs in Brugada syndrome"],"prefix":"10.1093","volume":"20","author":[{"given":"Ibrahim","family":"El-Battrawy","sequence":"first","affiliation":[{"name":"Faculty of Medicine, First Department of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, First Department of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Lang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, First Department of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, First Department of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, First Department of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"key\n\t\t\t\t20180607083728_eux358-B1","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/eux198","article-title":"Feasibility evaluation of long-term use of beta-blockers and calcium antagonists in patients with Brugada syndrome","volume":"20","author":"Kamakura","year":"2018","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180607083728_eux358-B2","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/CIRCRESAHA.117.311655","article-title":"Letter by El-Battrawy et al Regarding Article, \u201cThe Brugada syndrome susceptibility gene HEY2 modulates cardiac transmural ion channel patterning and electrical heterogeneity\u201d","volume":"121","author":"El-Battrawy","year":"2017","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180607083728_eux358-B3","article-title":"The Brugada syndrome susceptibility gene HEY2 modulates cardiac transmural ion channel patterning and electrical heterogeneity","author":"Veerman","year":"2017","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180607083728_eux358-B4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.hrthm.2004.11.025","article-title":"Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome","volume":"2","author":"Wolpert","year":"2005","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180607083728_eux358-B5","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jacc.2017.08.029","article-title":"Patients with Brugada syndrome and implanted cardioverter-defibrillators: long-term follow-up","volume":"70","author":"Hernandez-Ojeda","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/20\/FI1\/f137\/25019050\/eux358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T10:52:41Z","timestamp":1570618361000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/FI1\/f137\/4817088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":5,"journal-issue":{"issue":"FI1","published-online":{"date-parts":[[2018,1,18]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eux358","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,1,18]]}}}